Advertisement
Canada markets open in 1 hour 55 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7316
    +0.0018 (+0.25%)
     

  • CRUDE OIL

    82.99
    +0.18 (+0.22%)
     

  • Bitcoin CAD

    87,237.52
    -3,777.41 (-4.15%)
     

  • CMC Crypto 200

    1,355.01
    -27.56 (-1.99%)
     

  • GOLD FUTURES

    2,340.60
    +2.20 (+0.09%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,489.50
    -175.00 (-0.99%)
     

  • VOLATILITY

    16.23
    +0.26 (+1.63%)
     

  • FTSE

    8,091.40
    +51.02 (+0.63%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Today’s Research Reports on Titan Medical, ProMIS Neurosciences, Cardiome Pharma and Valeant Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / May 8, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Titan Medical Inc.
https://rdinvesting.com/news/?ticker=TMD.TO

ProMIS Neurosciences, Inc.
https://rdinvesting.com/news/?ticker=PMN.TO

Cardiome Pharma Corp.
https://rdinvesting.com/news/?ticker=COM.TO

Valeant Pharmaceuticals International, Inc.
https://rdinvesting.com/news/?ticker=VRX.TO

ADVERTISEMENT

Titan Medical's stock moved 5.77% lower Monday, to close the day at $0.24. The stock recorded a trading volume of 142,150 shares, which was below its three months average volume of 759,124 shares. In the last year, Titan Medical's shares have traded in a range of 0.13 - 0.68. The share price has gained 88.46% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.263 is below its 200-day moving average of $0.38. Shares of Titan Medical have fallen approximately 35.53 percent year-to-date.

Access RDI's Titan Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TMD.TO

On Monday, shares of ProMIS Neurosciences recorded a trading volume of 85,320 shares, which was below the three months average volume of 456,473 shares. The stock ended the day 3.66% lower at 0.395. The share price has gained 119.44% from its 52 week low with a 52 week trading range of 0.18 - 0.73. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.44 is greater than its 200-day moving average of $0.354. Shares of ProMIS Neurosciences have gained approximately 97.50 percent year-to-date.

Access RDI's ProMIS Neurosciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PMN.TO

Cardiome Pharma's stock moved 1.67% lower Monday, to close the day at $2.95. The stock recorded a trading volume of 14,858 shares, which was below its three months average volume of 22,288 shares. In the last year, Cardiome Pharma's shares have traded in a range of 1.64 - 6.06. The share price has gained 79.88% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.83 is greater than its 200-day moving average of $2.14. Shares of Cardiome Pharma have gained approximately 54.45 percent year-to-date.

Access RDI's Cardiome Pharma Corp. Research Report at:
https://rdinvesting.com/news/?ticker=COM.TO

On Monday, shares of Valeant Pharmaceuticals recorded a trading volume of 1,024,216 shares, which was below the three months average volume of 1,202,188 shares. The stock ended the day 1.21% higher at 23.46. The share price has gained 76.39% from its 52 week low with a 52 week trading range of 13.30 - 30.56. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $21.35 is below its 200-day moving average of $22.22. Shares of the company are trading at a Price to Earnings ratio of 3.43. Shares of Valeant Pharmaceuticals have fallen approximately 10.46 percent year-to-date.

Access RDI's Valeant Pharmaceuticals International, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=VRX.TO

Our Actionable Research on Titan Medical Inc. (TSX:TMD.TO), ProMIS Neurosciences, Inc. (TSX:PMN.TO), Cardiome Pharma Corp. (TSX:COM.TO) and Valeant Pharmaceuticals International, Inc. (TSX:VRX.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute

SOURCE: RDInvesting.com